Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Did the BPC-157 peptide get approved by the FDA in 2026
PubMed laboratory research record [PMID: 6525623] PubMed record related to this compound for laboratory literature review
2005 Jan;86(1):150-3
and the conversion of 5-methyltetrahydrofolate to tetrahydrofolate, a process necessary for DNA synthesis and red blood cell production
Injection technique with 5mg vials Drawing the dose Reconstituted with 2ml water (2,500mcg/ml): 250mcg = 10 units 500mcg = 20 units Process : Wipe vial top with alcohol Draw air into syringe (same amount as dose) Inject air into vial Invert vial Draw solution slowly Remove needle, check for air bubbles Tap syringe to remove bubbles Injection sites Best locations for subcutaneous injection: Abdomen (2 inches from belly button) Front of thigh Back of upper arm (harder to self-inject) Site-specific injection (optional): Can inject near injury site for localized effect
BPC-157 dostpny jest w postaci doustnych kapsuek lub podskrnych zastrzykw
